News | July 08, 2024
Aster Health Academy announces strategic partnerships with premier Hospitals across India
The academy has secured partnerships with 15 esteemed hospitals
The academy has secured partnerships with 15 esteemed hospitals
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The company will now explore a buyer for its manufacturing site and exit in due course
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Profit Before Tax is Rs. 220 crore, registering a commendable 64% growth
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
95.7% of patients responded to Breyanzi in the TRANSCEND FL trial
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating anaemia in Chronic Kidney Disease (CKD) patients
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
